Cite
HARVARD Citation
Di Lorenzo, A. et al. (2022). Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. Oncoimmunology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Di Lorenzo, A. et al. (2022). Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. Oncoimmunology. p. . [Online].